Pathologists take note! Human whole-genome sequencing of tumors was the source of information for making treatment decisions in a recently-published study. For the first time, researchers conducted a large trial involving testing the entire genome of individual breast cancers with the aim of personalized treatment. Pathologists and clinical laboratory administrators can view this latest study as another sign that genetic testing and molecular testing are moving at a pace to become as important as traditional diagnostic methods.
View the original article here: Whole-Genome Sequencing Trials Suggest Time Has Come to Bring Personalized Medicine to Cancer Field
